Investment analysts at Wedbush boosted their FY2025 earnings estimates for shares of Fennec Pharmaceuticals in a research ...

In-theater advertising company National CineMedia Inc. is well-positioned to reap the benefits of cinema’s unique proposition ...

Arvinas (NASDAQ:ARVN – Get Free Report) was downgraded by analysts at Wedbush from an “outperform” rating to a “neutral” ...

Wedbush said Friday it expects North American box office to rise at least 7% in 2025, with double-digit growth in the second ...

Wedbush analyst Richard Anderson maintained a Sell rating on CareTrust REIT (CTRE – Research Report) today and set a price target of $26.00.

Stacey Winter joined Wedbush Securities in 2002 and currently serves as managing director, head of equity sales and head of ...

Wedbush raised the firm’s price target on Rubrik (RBRK) to $80 from $75 and keeps an Outperform rating on the shares. The firm notes Rubrik ...

"We see continued strong demand," Rubrik co-founder and CEO Bipul Sinha told me on Yahoo Finance on Friday. Sinha's comments ...

It’s been a bad month for the stock market. But it’s been a terrible month—in fact, a terrible year—for Tesla. Even after ...

Investors have an opportunity to buy and hold quality growth stocks amid the ongoing selloff in 2025. Today, fundamentally ...

While Europe boycotts Tesla over chief executive Elon Musk’s political activities, the electric vehicle company appears to ...

New York (CNN) — US stocks slid Thursday and the S&P 500 closed in correction, down more than 10% from its record high in ...